Development and Validation of a TyG Index Based Model for Predicting Metabolic Syndrome Risk in a Western Chinese Plateau Population
Background/Objectives: To examine the association between the triglyceride-glucose (TyG) index, a surrogate marker of insulin resistance, and metabolic syndrome (MetS), and to develop a model for predicting MetS risk to support early prevention. Methods: Participants were free of MetS at baseline in 2016 and had ascertainable follow-up outcomes in 2026. Baseline measurements were candidate predictors, and MetS detected at follow-up was the binary outcome. Continuous and categorical variables were compared using the Mann–Whitney U test and Pearson’s chi-square or Fisher’s exact test, respectively. Variables with an overall p < 0.20 in univariable logistic regression entered LASSO logistic regression. Predictors were selected using stratified tenfold cross-validation and the one-standard-error rule. Eight selected variables were entered into multivariable logistic regression to estimate adjusted odds ratios and construct a nomogram. Logistic regression and random forest models using these fixed predictors were assessed with the same stratified tenfold splits. Out-of-fold AUCs and Brier scores were calculated, and random forest calibration and decision curves were plotted. Results: The study included 1304 participants. Eight predictors were selected: age, body weight, BMI, LDL-C, uric acid, HbA1c, left forearm T-score, and TyG index. Each one-unit increase in TyG was associated with an adjusted odds ratio of 1.86 (95% CI 1.41–2.47; p < 0.001). The random forest model had apparent and out-of-fold AUCs of 0.833 and 0.748, and Brier scores of 0.1478 and 0.1716, respectively. Out-of-fold decision curves indicated greater estimated net benefit than screening all or no participants at thresholds of 20%, 30%, and 40%. Conclusions: The TyG-centered MetS risk prediction model showed moderate discrimination and calibration. Its performance and clinical utility require evaluation in an independent population before use in screening.
Authors
- Yide Ma (ORCID: https://orcid.org/0000-0001-6098-7853)
- Zhenhua Wang (ORCID: https://orcid.org/0000-0003-3386-7711)
- Haixia Qi
- Xiao Liu
- Lihua Ma
- Yahui Yu
- Zhiqian Zhang
Institutions
- First Hospital of Lanzhou University (CN)
- Lanzhou University (CN)
Publication Details
- Journal
- Healthcare
- Published
- 2026-11-18
- DOI
- https://doi.org/10.3390/healthcare14223955
- Primary Topic
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China